Curis’s stock rises as analysts see ‘the next Pharmacyclics’

Shares of Curis rose premarket Friday as analysts see biotech company as potential take-out target
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.